June 10, 2025

Does Combination Therapy Improve Albuminuria?

Finerenone plus empagliflozin reduced urinary albumin-to-creatinine ratio by 29% to 32% more than either drug alone in patients with chronic kidney disease and type 2 diabetes.

Conexiant

June 10, 2025

Does Autism-Linked Cortical Noise Impair Sleep?

New research presented at SLEEP 2025 links increased auditory cortex excitability with poor sleep efficiency in children—especially those with autism spectrum disorder—offering insight into sensory-driven sleep disturbances.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant

June 03, 2025

Phytosterols May Shield Against Diabetes, CVD

Large Harvard study shows higher phytosterol intake, particularly beta-sitosterol, reduces type 2 diabetes and cardiovascular disease risk by up to 9%.

Conexiant

May 30, 2025

Major Medical Societies Issue GLP-1 Nutrition Guidelines

New advisory addresses nutritional challenges and side effects for obesity treatment

Conexiant

May 20, 2025

ICU Sedation Economics: A $1 Difference

Study finds dexmedetomidine, clonidine, and propofol have comparable cost-effectiveness for critically ill patients on mechanical ventilation.

Conexiant

May 19, 2025

Could New COPD Criteria Double Diagnosis Rates?

Multidimensional schema incorporating CT imaging and symptoms identifies high-risk patients without traditional airflow obstruction.

Conexiant

May 06, 2025

Shorter Prostate Radiotherapy Proves Long-Term Match

Two-week radiation treatment for localized prostate cancer delivers equivalent 10-year outcomes to standard 8-week course in a clinical trial.

Conexiant

April 21, 2025

Risk-Free Midlife: 10+ Years Longer Living

Prioritizing the prevention and treatment of the modifiable risk factors could substantially extend healthy life expectancy worldwide.

Conexiant